Stocks
GlaxoSmithKline (GSK) P/E US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 28.7 | 30.9 | 15.2 | 26.8 | 8.69 | 17.4 | ||
| Changes by years, y/y, % | +508% | +8% | -51% | +76% | -68% | -7.4% | |||
GlaxoSmithKline. P/E
GlaxoSmithKline. P/E, changes, %
GlaxoSmithKline (GSK) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | 25.1 | 22.8 | 15.8 | 8.62 | 19.0 | 17.4 | |
| Changes by years, y/y, % | +29% | -41% | -52% | -68% | -24% | |||
| Changes by quarters, q/q, % | -6% | -9% | -30% | -46% | +121% | |||
